Skip to main content
. 2012 Mar 14;2012(3):CD005217. doi: 10.1002/14651858.CD005217.pub2
Methods ‐ Single centre, Denmark (Copenhagen)
‐ Study period not reported
‐ Follow‐up visit after 2 weeks
Participants ‐ 102 women randomised, 81 analysed
‐ Women presenting for surgical abortion in first trimester
‐ Exclusion criteria: allergy to treatment; treatment with antibiotics at the time of abortion; active haematological or neurological disease; alcohol abuse or treatment with disulfiram (Antabuse); positive test for N. gonorrhoeae
‐ Preoperative infections:
1) History of PID: all women, 43/43 in arm 1 and 38/38 in arm 2
2) Chlamydia: not reported
3) Gonorrhoea: all tested, none positive
4) Bacterial vaginosis: not reported
Interventions Antibiotic prophylaxis compared with alternative regimens of the same antibiotic
‐ Intervention, arm 1: metronidazole 400 mg, oral (peri‐operative 3 doses, 1h before, 4h after and 8h after abortion)
‐ Control, arm 2: pivampicillin 350 mg, oral (peri‐operative 3 doses, 1h before, 4h after and 8h after abortion)
Outcomes 1) Post‐abortal PID defined as:
a) Patient seen at follow‐up visit after 2 weeks, at least 3 of the following: temperature > 38 °C; continued pelvic pain; malaise with tender adnexal mass; pathologic discharge or bleeding
b) Patient admitted before scheduled follow‐up, at least 2 of the following: temperature > 38 °C; moderate tenderness of the uterus; tender adnexal mass; pathologic discharge or bleeding
2) Re‐admission to hospital
Notes Not universal antibiotic prophylaxis according to protocol definition; study population included only women without gonorrhoea at baseline. All had a history of PID
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk
Incomplete outcome data (attrition bias) Low risk